Medtronic (MDT) Net Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -431.25% |
| Oct 24, 2025 | 104.74% |
| Jul 25, 2025 | -245.61% |
| Apr 25, 2025 | 2,995.83% |
| Jan 24, 2025 | -130.38% |
| Oct 25, 2024 | 2,075.00% |
| Jul 26, 2024 | 98.56% |
| Apr 26, 2024 | -204.12% |
| Jan 26, 2024 | 81.63% |
| Oct 27, 2023 | 189.09% |
| Jul 28, 2023 | 94.32% |
| Apr 28, 2023 | -242.98% |
| Jan 27, 2023 | -130.36% |
| Oct 28, 2022 | 292.15% |
| Jul 29, 2022 | -483.11% |
| Apr 29, 2022 | -38.27% |
| Jan 28, 2022 | 746.32% |
| Oct 29, 2021 | 82.63% |
| Jul 30, 2021 | 62.66% |
| Apr 30, 2021 | -3.53% |
| Jan 29, 2021 | -1,014.17% |
| Oct 30, 2020 | -105.66% |
| Jul 31, 2020 | 344.55% |
| Apr 24, 2020 | 289.14% |
| Jan 24, 2020 | 75.50% |
| Oct 25, 2019 | -259.12% |
| Jul 26, 2019 | -1.86% |
| Apr 26, 2019 | 414.41% |
| Jan 25, 2019 | 50.22% |
| Oct 26, 2018 | -157.77% |
| Jul 27, 2018 | 128.82% |
| Apr 27, 2018 | -445.68% |
| Jan 26, 2018 | -4.67% |
| Oct 27, 2017 | 353.27% |
| Jul 28, 2017 | -114.67% |
| Apr 28, 2017 | 1,343.18% |
| Jan 27, 2017 | -91.30% |
| Oct 28, 2016 | -186.79% |
| Jul 29, 2016 | 221.21% |
| Apr 29, 2016 | -91.56% |
| Jan 29, 2016 | 166.27% |
| Oct 30, 2015 | 69.17% |
| Jul 31, 2015 | 84.25% |
| Apr 24, 2015 | -175.94% |
| Jan 23, 2015 | 266,800.00% |
| Oct 24, 2014 | 88.24% |